5 March 2018 - UnitedHealth Group, the nation’s largest health insurance company, says it’s paying nearly 60% of its reimbursements ...
22 February 2018 - Value assessment is an integral component of decision making in health and is the focus of a ...
20 February 2018 - The QALY is a useful outcome measure in cost-effectiveness analysis. But in determining the overall value of ...
19 January 2018 - Preference elicitation studies reporting societal views on the relative value of end-of-life treatments have produced equivocal results. ...
25 January 2018 - Concern over pricing of pharmaceuticals and other health technologies in both high- and low-income countries is not ...
23 January 2018 - Payers often assess the benefits of new drugs relative to costs for reimbursement purposes, but they frequently ...
23 January 2018 - Although health technology assessment systems base their decision making process either on economic evaluations or comparative clinical ...
22 December 2017 - The objective of this study was to estimate the expected incremental cost per quality-adjusted life-year (QALY) ...
28 December 2017 - Modern immuno-oncology agents have generated great excitement because of their potential to provide durable survival for some ...
28 December 2017 - The cost of generating a quality-adjusted life year within a National Health Service provides an approximation of ...
15 December 2017 - Value Assessment? Yes, But How? ...
30 November 2017 - NHS England will issue guidance to GPs and commissioners to limit the prescribing of “low value” ...
30 November 2017 - Lorica Health's CEO Paul Nicolarakis says the health analytics company is helping the industry and government ...
4 October 2017 - Evidence about cost-effectiveness is increasingly being used to inform decisions about the funding of new technologies that ...
6 October 2017 - A focus on expediting drug development. ...